Delivery Order SPE2DX22D0049-SPE2D826FA2LD
- Not listed
- This delivery order, awarded on December 1, 2025, represents a $31,367.68 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award is non-competitive and carries an ultimate completion date of December 2, 2025. Work will be...
- This delivery order, issued on November 17, 2025, awards $36,140.72 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) for pharmaceutical and medical supply provision under a firm fixed-price contract. The award is non-competitive and represents a child order under the company's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999.00 through December 2026. The work will be performed at the contractor's Corporate Office...
- This delivery order, awarded December 1, 2025, represents a $1,139.73 firm fixed-price contract to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) for pharmaceutical and medical supply delivery. The contract is funded by the Defense Logistics Agency's Medical Supply Chain, a defense agency function, with performance to be completed by December 2, 2025, at the company's corporate headquarters in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside...
- On December 8, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $10,814.50 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This firm fixed-price delivery order, with an ultimate completion date of December 9, 2025, was competitively awarded with no set-aside designation. The award represents a child contract action under AmerisourceBergen's broader Indefinite Delivery...
- This delivery order, awarded on December 8, 2025, represents a $12,279.88 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This delivery order involves pharmaceutical and medical supply products to be performed at...
- This delivery order, awarded November 5, 2025, represents a $1,353.48 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The order, which is expected to be completed by November 6, 2025, is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. This prime indefinite delivery...
- This delivery order, awarded on October 28, 2025, represents a $7,702.73 firm fixed-price contract issued to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) by the Defense Logistics Agency's Medical Supply Chain division. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award is non-competitive, reflecting the established relationship under the prime...
- This delivery order, awarded December 7, 2025, represents a $8,654.40 firm fixed-price contract to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) for pharmaceutical and medical supply delivery. The contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, designated SPE2DX and valued at $999.999 billion through December 2026. This award was made competitively with no set-aside designation and will...
- This delivery order, issued on October 2, 2025, awards $1,131.72 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) for pharmaceutical and medical supplies to support federal healthcare needs. The contract is funded by the Defense Logistics Agency's Medical Supply Chain and is structured as a firm fixed-price delivery order with an ultimate completion date of October 3, 2025. The award is not set-aside and represents a competitive award to the prime contractor's corporate office located in...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a $47,051.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on December 1, 2025, with an ultimate completion date of December 2, 2025. This non-set-aside competitive award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contractor, headquartered in Conshohocken,...
- SPE2DX22D0049Indefinite Delivery Contract
- SPE2DX22D0049-SPE2D826FA2LDDelivery Order
This delivery order, issued on December 8, 2025, awards $40,149.75 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) under a firm fixed price contract with an ultimate completion date of December 9, 2025. The award is funded through the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for pharmaceutical and medical supply procurement for military and veteran healthcare systems. The contract is non-competitive and represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs. The company supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs, including brand-name and generic medications, vaccines, specialized treatments for neurological and endocrine conditions, pain management pharmaceuticals, and medical devices. The underlying IDC vehicle supports the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with the DLA planning to establish next-generation Pharmaceutical Prime Vendor Global Program contracts involving multiple regional awards to various contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $40.1k | 12/7/25 |